Literature DB >> 7264542

Expression of serologically detectable H-2 antigens on mid-gestation mouse embryonic tissues.

K J Kirkwood, W D Billington.   

Abstract

Mixed haemadsorption assays using antibody-coated indicator sheep erythrocytes and mouse alloantisera revealed that major histocompatibility complex (H-2) antigens were expressed on cells of 24-72 h cultures of mid-gestation mouse embryonic skin, gut, lung, limb-bud and heart but not of embryonic gonad or kidney. The precise time of detection of H-2 antigen expression and the proportions of cells expressing these determinants depended on inbred strain, specific haplotype, tissue of origin and antiserum batch employed. In all tissues the proportion of cells expressing H-2 increased progressively from day 11-12 post-coitum onwards. The findings are discussed with respect to hypotheses concerning the possible role of major histocompatibility antigens in cellular recognition and interactions during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264542

Source DB:  PubMed          Journal:  J Embryol Exp Morphol        ISSN: 0022-0752


  4 in total

1.  Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.

Authors:  K Ozato; Y J Wan; B M Orrison
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Fetal allograft survival in immunocompetent recipients is age dependent and organ specific.

Authors:  R P Foglia; J DiPreta; M B Statter; P K Donahoe
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

3.  Expression of H-2 class I genes in murine extra-embryonic tissues.

Authors:  K L Philpott; S Rastan; S Brown; A L Mellor
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

4.  Humoral immune responses in murine pregnancy. II. Kinetics and nature of the response in females preimmunized against paternal alloantigens.

Authors:  R Roe; S C Bell
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.